tyrosyl-arginyl-phenylalanyl-lysinamide has been researched along with Bradyarrhythmia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clapp, JF; Kett, A; Kim, H; Olariu, N; Omoniyi, AT; Szeto, HH; Wu, D | 1 |
| Clapp, JF; Kett, A; Omoniyi, AT; Soong, Y; Szeto, HH; Wu, D | 1 |
2 other study(ies) available for tyrosyl-arginyl-phenylalanyl-lysinamide and Bradyarrhythmia
| Article | Year |
|---|---|
Baroreflex-mediated bradycardia but not tachycardia is blunted peripherally by intravenous mu-opioid agonists.
Topics: Animals; Baroreflex; Blood Pressure; Bradycardia; Female; Heart Rate; Naloxone; Nitroprusside; Norepinephrine; Oligopeptides; Pregnancy; Quaternary Ammonium Compounds; Receptors, Opioid, mu; Sheep; Tachycardia | 1998 |
A peripheral site of action for the attenuation of baroflex-mediated bradycardia by intravenous mu-opioid agonists.
Topics: Animals; Anti-Arrhythmia Agents; Baroreflex; Bradycardia; Catheters, Indwelling; Drug Interactions; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Female; Naloxone; Narcotic Antagonists; Nitroprusside; Norepinephrine; Oligopeptides; Pregnancy; Quaternary Ammonium Compounds; Receptors, Opioid, mu; Sheep | 2000 |